Biopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services
Penny Bemus, MBA, JD, Centric Health Resources
Advertisement
Articles by Penny Bemus, MBA, JD, Centric Health Resources
Advertisement
Latest Updated Articles
- Building an Alternative Distribution Model for Ultra-Orphan Diseases
February 27th 2009
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cencora-Kite Agreement Signals CGT Commercialization Shift
2
Wegovy Pill's UAE Debut Is a Distribution Story, Not Just a Market Entry
3
Q&A: Dr. Reddy's CEO on Generic Semaglutide and the GLP-1 Market Ahead
4
Q&A: Why Pharma Needs to Rethink Its Path to the Patient
5